HCM

Health Care Sector Update for 03/06/2018: CLSD, MRNS, HCM, BMY

A generic image of two people across each other Credit: Shutterstock photo

Top Health-care stocks:

JNJ: flat

PFE: +0.01%

ABT: flat

MRK: +0.5%

AMGN: +0.8%

Health care shares were steady ahead of the bell on Tuesday.

Expected movers:

- Clearside Biomedical ( CLSD ): enrols first patient in trial for macular edema linked to retinal vein occlusion

- Marinus ( MRNS ): narrows 2017 loss vs last year

Other news:

- Hutchison China MediTech ( HCM ): starts proof-of-concept trial of Epitinib in glioblastoma in China

- Bristol-Myers Squibb ( BMY ): secures FDA approval on Opdivo label update for cancers

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

More Related Articles

Sign up for Smart Investing to get the latest news, strategies and tips to help you invest smarter.